Modifiers of the oligomycin sensitivity of the mitochondrial F1F0-ATPase

Alessandra Pagliarani1, Salvatore Nesci, Vittoria Ventrella

  • 1Department of Veterinary Medical Sciences, University of Bologna, Bologna, Italy. alessandra.pagliarani@unibo.it

Mitochondrion
|April 20, 2013
PubMed

Insights

Oligomycin antibiotics target the mitochondrial F₁F₀ complex, inhibiting ATP production. Altered sensitivity to these drugs reveals functional defects linked to mitochondrial diseases and may guide new drug design.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cellular Respiration

Background:

  • The mitochondrial F₁F₀ complex is crucial for ATP synthesis and energy production.
  • Macrolide antibiotics, particularly oligomycins, inhibit this complex by binding to the F₀ subunit.
  • Oligomycin sensitivity serves as an indicator of the F₁F₀ complex's functional integrity.

Purpose of the Study:

  • To explore the multifaceted factors influencing oligomycin sensitivity in the mitochondrial F₁F₀ complex.
  • To establish the connection between altered oligomycin sensitivity and pathological conditions involving ATPase dysfunction.
  • To highlight the potential for improved drug design targeting mitochondrial dysfunctions.

Main Methods:

  • Review of existing literature on oligomycin interactions with the F₁F₀ complex.
  • Analysis of factors affecting drug binding and proton transport inhibition.
  • Correlation of oligomycin sensitivity changes with known mitochondrial pathologies.

Main Results:

  • Oligomycin binding to the F₀ subunit is sensitive to amino acid substitutions, affecting inhibition efficiency.
  • Membrane properties, xenobiotic interactions, and F₁ sector detachment influence oligomycin sensitivity.
  • Altered oligomycin sensitivity is linked to various physiopathological conditions characterized by defective ATPases.

Conclusions:

  • Oligomycin sensitivity is a sensitive readout of mitochondrial F₁F₀ complex function and integrity.
  • Understanding the modulators of oligomycin sensitivity can illuminate mechanisms of mitochondrial disease.
  • This knowledge can facilitate the development of novel therapeutic strategies against oxidative damage in mitochondrial disorders.

Related Concept Videos

ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
ATP Synthase: Structure01:18

ATP Synthase: Structure

ATP synthase or ATPase is among the most conserved proteins found in bacteria, mammals, and plants. This enzyme can catalyze a forward reaction in response to the electrochemical gradient, producing ATP from ADP and inorganic phosphate. ATP synthase can also work in a reverse direction by hydrolyzing ATP and generating an electrochemical gradient. Different forms of ATP synthases have evolved special features to meet the specific demands of the cell. Based on their specific feature, ATP...
Electron Transport Chain: Complex III and IV01:43

Electron Transport Chain: Complex III and IV

During the electron transport chain, electrons from NADH and FADH2 are first transferred to complexes I and II, respectively. These two complexes then transfer the electrons to ubiquinol, which carries them further to complex III. Complex III passes the electrons across the intermembrane space to Cyt c, which carries them further to complex IV. Complex IV donates electrons to oxygen and reduces it to water. As electrons pass through complexes I, III, and IV, the energy released aids the pumping...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Chemiosmosis and ATP Synthesis01:22

Chemiosmosis and ATP Synthesis

The electron transport chain is a critical component of cellular respiration, occurring in the inner mitochondrial membrane. It facilitates the transfer of high-energy electrons from reduced cofactors NADH and FADH₂ to molecular oxygen, the final electron acceptor. This transfer of electrons through a series of protein complexes is tightly coupled to the translocation of protons across the membrane, generating a proton gradient essential for ATP synthesis.Electron Flow and Proton...